Rankings
▼
Calendar
AMPH Q4 2017 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$860M
Q4 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$60M
-4.9% YoY
Gross Profit
$21M
34.1% margin
Operating Income
-$2M
-2.8% margin
Net Income
$1M
2.4% margin
EPS (Diluted)
$0.03
QoQ Revenue Growth
+4.3%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
-$353,000
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$455M
Total Liabilities
$117M
Stockholders' Equity
$337M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$60M
$64M
-4.9%
Gross Profit
$21M
$20M
+3.1%
Operating Income
-$2M
-$5M
+63.1%
Net Income
$1M
-$3M
+153.5%
Revenue Segments
Active Pharmaceutical Ingredient Segment
$4M
100%
Geographic Segments
U
$59M
100%
← FY 2017
All Quarters
Q1 2018 →